Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
Analyst Update on Agilon Health: J.P. Morgan analyst Lisa C. Gill has revised estimates for Agilon Health following their fourth-quarter results, which showed an adjusted EPS loss of $(0.26) against a consensus of $(0.23), while sales met expectations at $1.52 billion. The outlook for 2025 indicates a transition year with revised revenue estimates down to $5.926 billion.
Stock Performance and ETFs: Agilon Health shares are currently down 0.48% at $4.18, and investors can gain exposure through Fidelity Disruptive Medicine ETF (FMED) and SPDR S&P Health Care Services ETF (XHS).
Trade with 70% Backtested Accuracy
Analyst Views on FMED
No data
About the author
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
Analyst Update on Agilon Health: J.P. Morgan analyst Lisa C. Gill has revised estimates for Agilon Health following their fourth-quarter results, which showed an adjusted EPS loss of $(0.26) against a consensus of $(0.23), while sales met expectations at $1.52 billion. The outlook for 2025 indicates a transition year with revised revenue estimates down to $5.926 billion.
Stock Performance and ETFs: Agilon Health shares are currently down 0.48% at $4.18, and investors can gain exposure through Fidelity Disruptive Medicine ETF (FMED) and SPDR S&P Health Care Services ETF (XHS).
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
Analyst Update on Agilon Health: J.P. Morgan analyst Lisa C. Gill has revised estimates for Agilon Health following their fourth-quarter results, which showed an adjusted EPS loss of $(0.26) against a consensus of $(0.23), while sales met expectations at $1.52 billion. The outlook for 2025 indicates a transition year with revised revenue estimates down to $5.926 billion.
Stock Performance and ETFs: Agilon Health shares are currently down 0.48% at $4.18, and investors can gain exposure through Fidelity Disruptive Medicine ETF (FMED) and SPDR S&P Health Care Services ETF (XHS).
